SPY422.11-2.37 -0.56%
DIA340.76-2.65 -0.77%
IXIC14,039.68-33.17 -0.24%

BRIEF-Polarityte Inc Says Diabetic Foot Ulcer Trial Met Primary And Secondary Endpoint

05/10/2021 08:43
BRIEF-Polarityte Inc Says Diabetic Foot Ulcer Trial Met Primary And Secondary Endpoint

- PolarityTE Inc PTE.O:

  • POLARITYTE INC - DIABETIC FOOT ULCER TRIAL MET PRIMARY AND SECONDARY ENDPOINT

Source text for Eikon: ID:nBw90Qv8na

Further company coverage: PTE.O


(([email protected];))